查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1852894

神經外科器械市場按產品類型、最終用戶、應用和手術方式分類－2025-2032年全球預測

Neurosurgery Devices Market by Product Type, End User, Application, Procedure - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經外科器械市場規模將達到 356.4 億美元，複合年成長率為 13.27%。

關鍵市場統計數據
基準年 2024 131.5億美元
預計年份：2025年 149.1億美元
預測年份 2032 356.4億美元
複合年成長率 (%) 13.27%

神經外科器械的綜合發展方向，重點在於技術融合、臨床應用壓力、監管演變及其對策略決策的影響

隨著技術創新與不斷變化的醫療服務模式和日益成長的臨床期望相融合，神經外科器械的研發正在加速發展。該領域如今涵蓋了從生物活性移植物材料和先進植入系統到高解析度內視鏡和導航平台等各個方面，這些設備能夠實現精準手術。同時，臨床實踐正朝著微創方向發展，醫療系統在採用新技術之前，要求提供強力的安全性、有效性和經濟價值證據。這些動態正在重塑製造商和供應商的採購偏好、臨床工作流程和競爭定位。

同時，法律規範和支付方的期望正將重點轉向真實世界結果和上市後監測，這提升了整合資料收集和縱向臨床研究的重要性。投資人也積極回應，支持那些不僅展現出技術差異化，而且具有可重複的臨床效益和可靠商業化路徑的公司。因此，產品藍圖的設計以模組化和互通性為核心，預計將包含與導航系統、神經刺激平台和數位臨床決策支援系統的整合。

本導言為後續分析奠定了基礎，該分析將臨床趨勢、醫療設備創新、終端用戶行為以及更廣泛的地緣政治和監管變化聯繫起來。下文將探討不斷變化的格局、關稅的營運影響、細分市場洞察、區域動態、競爭格局、可操作的建議、調查方法以及對塑造神經外科未來領導者的啟示。

分析技術創新、臨床實踐轉變、監管力度加大以及商業性結構重組等因素的融合，這些因素正在重塑神經外科器械的研發和應用。

神經外科器材領域正經歷技術、臨床、監管和商業性的變革。在技​​術方面，診斷成像、電磁和光學導航以及微型內視鏡的進步，使外科醫生能夠以更高的精度進行手術，並減少周圍組織的損傷。這些進步與改良的植入材料和生物佐劑相輔相成，旨在促進骨癒合和神經組織相容性，從而改善患者的長期預後。機器人輔助和人工智慧驅動的影像引導正從實驗性工具轉變為實用工具，能夠減少手術操作的差異性，並縮短複雜手術的學習曲線。

臨床上，微創手術和門診病人治療的興起正在改變手術方式，並推動對能夠縮短手術時間和加快術後恢復的器械和設備的需求。隨著人們對神經調控機制的理解不斷加深，神經刺激技術，特別是深部腦部刺激和迷走神經刺激，其適應症不斷擴大，重新引起了人們的關注。同時，對病患報告結果和品質指標的日益重視，也提高了臨床證據的門檻，進而影響了技術的採納和報銷。

監管和報銷環境也在發生變化，監管機構要求提供更全面的上市後數據，而支付方則尋求可證明的價值，例如減少併發症、縮短住院時間和改善功能性結果。在商業方面，成熟的醫療技術公司、專業器材創新者和臨床研究網路之間的合作正在加速商業化進程，同時也改變了競爭動態。總而言之，這些變化為企業帶來了機會和執行風險，企業必須將產品創新與臨床效用和監管要求結合。

評估關稅引發的成本壓力和供應鏈調整如何改變了神經外科器械製造商的籌資策略、產品設計選擇和上市時間表

美國2025年全年累積實施的新關稅政策，已在神經外科器械生態系統中引發了一系列營運和戰略應對措施。依賴國際供應鏈的製造商正面臨零件和成品到岸成本不斷上漲的局面，這給其利潤結構和定價策略帶來了壓力。為應對這項挑戰，許多公司已啟動短期戰術措施，例如重新調整生產運作、增加關鍵零件的庫存緩衝以及加快雙源認證流程，以減少對單一戰術性國的依賴。從長遠來看，關稅環境正促使企業重新評估其地理生產佈局，並加深對將生產遷回國內或多元化至其他成本更低的生產地點的考慮。

除了直接的成本影響外，關稅還影響著合作夥伴的選擇、合約談判和資金分配決策。採購團隊正在重新談判供應商契約，以納入關稅轉嫁條款，並爭取更優惠的前置作業時間和品質保證。策略團隊正在重新審視產品設計，簡化複雜的材料清單，減少對關稅敏感組件的依賴，並探索既能保持臨床性能又能降低成本風險的替代材料。臨床和監管團隊也參與其中，因為設計變更可能會引發額外的驗證工作和監管申報，從而影響產品上市時間。

此外，關稅引發的動態正在對臨床應用時間表和醫療系統採購行為產生後續影響，因為醫療服務提供者在評估新型醫療設備時會考慮潛在的供應波動和總擁有成本。投資者和企業發展機構都在重新調整其評估模型和夥伴關係時間表，以反映日益增加的不確定性。整體而言，關稅改革的累積影響正在加速供應鏈現代化進程，並提升具有韌性、合規性和以臨床為中心的商業化策略的重要性。

以細分市場主導的臨床和商業情報，將產品子類別、最終用戶偏好、應用和手術類型聯繫起來，有助於確定創新和市場進入策略的優先順序。

細分市場分析揭示了不同產品類別、最終用戶、臨床應用和手術方法中存在的細微機會和實施需求。產品類型涵蓋生物製藥、內視鏡、植入式器械、手術器械、導航系統和神經刺激設備。在生技藥品領域，骨移植材料和生長因子正日益受到關注，凸顯了對能夠與宿主組織整合以降低重新置換風險的材料的需求，而開發商則優先考慮生物活性、滅菌兼容性和供應鏈可追溯性。內視鏡分為軟式內視鏡和硬式內視鏡，其應用模式截然不同。軟式內視鏡在複雜解剖結構和門診病人手術中應用日益廣泛，而硬式內視鏡由於其影像穩定性，仍然是某些顱內和脊椎手術的首選。植入器械分為顱骨脊椎移植，其中顱骨植入主要包括顱骨植入和硬腦膜替代物，而脊椎移植主要包括融合器和椎弓根螺釘。這些考慮強調了植入生物相容性、模組化和易於固定的重要性，以縮短手術時間並降低併發症發生率。臨床團隊會對鑽頭、穿孔器、牽開器系統和超音波吸引器等器材進行評估，檢視其人體工學、消毒週期以及與微創入路的兼容性。導航系統分為電磁導航和光學導航，需要精確的抗蝕劑精度以及與影像處理設備的互通性。神經刺激設備，包括深層腦部刺激器和迷走神經刺激設備，正透過先進的導線技術和封閉回路型編程選項不斷發展，以支持不斷擴大的治療適應症。

終端使用者群體包括門診手術中心、醫院、研究機構和專科診所。門診手術中心對能夠實現當日出院的緊湊型、經濟高效的設備的需求日益成長，而醫院則優先考慮能夠與其現有影像和監測基礎設施整合並支援複雜病例的系統。研究機構和專科診所是早期採用者，它們提供臨床證據和概念驗證數據，以加速更廣泛的應用。

應用領域細分包括腦腫瘤、癲癇、水腦症、運動障礙、疼痛管理和脊髓疾病。每種應用都需要不同的臨床性能，從腫瘤手術中精確的切除邊緣到運動和疼痛適應症中長期刺激的持久性。手術方式細分包括內視鏡手術、雷射治療、微創手術和開放性手術，手術方式決定了器械的外形規格、消毒方案和器械包。整合這些細分視角，可以突顯未滿足的臨床需求和技術能力的交會點，以及有針對性的證據產生和商業化投資能夠產生最大影響的領域。

對全球主要地區的臨床基礎設施、監管差異、採購行為和加速推廣應用的策略路徑進行區域比較評估

美洲、歐洲、中東和非洲以及亞太地區的區域動態正在明確優先事項，並塑造產業計畫。在美洲，整合式醫療保健系統和先進的門診手術中心網路正在催生對能夠在各種醫療環境中展現明確經濟和臨床價值的醫療器材的需求。該地區的監管路徑日益與上市後證據的預期相一致，要求製造商投資於註冊登記和結果追蹤。歐洲、中東和非洲是一個異質性區域，其採購慣例巨大，因此，希望進入該市場的製造商需要根據每個國家的衛生技術評估流程調整打入市場策略，並與當地臨床倡導者合作以克服推廣障礙。在亞太地區，醫院基礎設施的快速擴張、神經外科手術量的成長以及政府主導的醫療保健能力投資正在推動對擴充性器械解決方案和本地製造夥伴關係關係的需求。在所有地區，供應鏈韌性、對監管協調的承諾以及數位化整合能力正成為影響採購決策和長期夥伴關係的關鍵差異化因素。

跨境因素進一步加劇了區域策略的複雜性。跨境臨床試驗、監管等效性計畫和多區域報銷試點計畫能夠加速全球上市，但也需要對監管申報、臨床證據包和培訓計畫進行周密協調。那些能夠利用卓越中心 (COE)夥伴關係、數位化培訓平台和靈活的定價結構來設計區域部署方案的製造商，將更有利於把早期臨床應用轉化為持續應用，並獲得有利的採購條款。

策略性企業行動和夥伴關係模式揭示了整合平台、專業創新者和契約製造的選擇如何影響商業化和規模化。

公司層面的行動揭示了當前競爭格局：成熟的醫療技術公司、專注於醫療器材的專業公司以及創新新興企業都在塑造神經外科的發展軌跡中扮演著各自獨特的角色。領先企業正投資於平台策略，將硬體、軟體和資訊服務結合，打造整合解決方案，以減少臨床差異並實現可衡量的療效。同時，一些關鍵企業也在推動局部創新，例如新型生技藥品、精密植入設計和新一代刺激導線，這些創新旨在解決特定的臨床難題，並可能成為合作或收購的理想主要企業。

在整個生態系統中，商業化策略的重點在於支持實證醫學證據產生、臨床醫生培訓、設備運作和臨床療效的服務模式。設備製造商、影像和導航供應商以及學術中心之間的策略夥伴關係正在加速產品檢驗和臨床醫生的認可。製造合作夥伴和合約服務供應商對於擴充性也至關重要，尤其對於那些選擇本地化生產以降低關稅和物流風險的公司而言更是如此。此外，那些優先考慮透明定價、健全的上市後監測和清晰的互通性標準的公司，在醫療系統的採購流程中更容易取得成功。公司洞察表明，市場呈現兩極化，平台型企業專注於整合解決方案，而專業創新者則致力於臨床差異化。

針對產品開發、供應鏈韌性、證據產生和商業化等各環節的可操作性跨職能指導，確保產品能夠被廣泛採用並獲得競爭優勢。

產業領導者應採取優先排序的跨職能方法，將產品創新與實證實踐、供應鏈韌性和以客戶為中心的商業化相結合。首先，在研發週期的早期階段就應納入臨床證據規劃，確保臨床試驗、註冊研究和真實世界資料收集能夠涵蓋對外科醫生、支付方和採購方至關重要的終點指標。這種積極主動的方法可以縮短商業化週期，並提升報銷地位。其次，應重新設計供應鏈策略，減少單一來源採購，並在關稅風險或物流中斷可能顯著影響手術時間的情況下，評估區域製造或雙重來源採購方案。投資於供應商資格確認和材料工程可以帶來永續的成本和品質優勢。

門診手術中心需要緊湊、經濟高效的解決方案，醫院追求互通性和服務可靠性，而專科診所則優先考慮臨床表現和培訓。應開發模組化平台和相容的設備生態系統，以減少採購摩擦，並實現漸進式升級，而非一次性全部更換。在營運方面，應透過數位化模擬和指導模式擴展臨床醫生培訓項目，以加快外科醫生技能提升並儘早獲取結果數據。監管和品質團隊應透過記錄上市後監測計畫並建立電子資料採集流程，為迭代提交做好準備，以確保符合當地法規要求。

最後，尋求與自身能力互補的合作夥伴關係，例如先進的導航技術、生物製藥生產和臨床研究網路。優先考慮與高影響力機構合作進行商業性試點項目，這些機構能夠產生可重複的結果，並可作為參考案例。透過實施這些建議，企業領導者可以提高產品長期應用的成功率，並在瞬息萬變的神經外科器械市場中打造穩固的競爭優勢。

一項透明的、混合方法的研究途徑，結合了從業人員訪談、臨床文獻、監管審查和情境分析，得出了可靠的結論。

本摘要綜合的研究途徑結合了定性專家訪談、對臨床醫生和採購負責人的初步調查，以及對臨床文獻和監管文件的嚴謹二次分析。初步訪談包括對神經外科醫生、手術室主管、醫院採購專家、器械工程師和衛生經濟學專家的結構化訪談，旨在了解臨床優先事項和採購動態。這些觀點與同行評審的臨床研究、器材註冊資訊和公開的監管文件進行交叉比對，以檢驗臨床性能聲明、安全性概況和上市後義務。

分析方法包括主題綜合分析，用於識別關鍵的臨床和商業性趨勢；情境分析，用於評估關稅變化和供應鏈中斷對營運的影響；以及細分映射，用於將設備屬性與最終用戶的需求和操作流程相匹配。品質保證通訊協定確保所有結論均有多個資訊來源支持，並透過後續訪談和敏感性檢查來協調相互矛盾的資訊。在處理原始資料時，我們充分考慮了倫理和合規性問題，並使用匿名化的訪談摘要結果來保護隱私，同時保留從業人員的深刻見解。

此調查方法框架整合了實踐者的見解和文獻證據，並透過情境規劃和敏感性評估明確地解決了不確定性領域，從而支持穩健且可操作的結論。

整合策略要務和風險考量，以決定哪些組織能夠在推動神經外科護理的臨床應用和商業性規模化方面取得成功。

神經外科器械生態系統正處於曲折點，技術、臨床需求、監管預期和地緣政治因素正在交匯融合，重塑投資和執行的優先事項。對於那些能夠將差異化器械功能與嚴謹的證據生成、穩健的供應鏈以及針對特定臨床和區域環境量身定做的商業化策略相結合的公司而言，機會比比皆是。反之，那些未能為關稅驅動的成本波動、日益嚴格的監管以及對可驗證療效不斷成長的需求做好準備的公司，則可能面臨產品推廣速度放緩和商業性回報縮水的風險。

領導者應專注於建立可互通的平台，投資於臨床醫生培訓和真實世界證據項目，並創建能夠最大限度降低中斷風險的供應鏈。策略夥伴關係和有針對性的併購可以加速獲取互補技術和臨床管道，而精心的產品設計選擇則可以降低醫療服務提供者的整體擁有成本。最終，在這個市場中取得成功的將是那些採用系統思維方法、將卓越的工程技術與臨床檢驗相結合，並採用能夠反映不同地區和不同類型醫療服務提供者實際情況的靈活商業化模式的組織。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 機器人輔助神經外科手術平台在精準腫瘤切除的應用日益廣泛
  • 脊椎神經外科對微創內視鏡工具的需求日益成長
  • 整合人工智慧成像系統以實現即時術中導航
  • 開發用於慢性深部腦部刺激的生物相容性神經植入
  • 用於靶向神經迴路控制的光遺傳神經調控裝置的進展
  • 可攜式中磁振造影系統正變得越來越普遍，提高了手術室的效率。
  • 擴展無線穿戴式感測器的應用範圍，用於術後持續神經系統監測

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 按產品類型分類的神經外科器械市場

  • 生物
    • 骨移植
    • 生長因子
  • 內視鏡檢查
    • 軟性內視鏡
    • 硬式內視鏡
  • 植入式裝置
    • 顱骨植入
      • 頭骨板
      • 杜拉替代品
    • 脊椎移植
      • 融合籠
      • 椎弓骨釘
  • 裝置
    • 鑽頭和穿孔器
    • 收縮器系統
    • 超音波吸引器
  • 導航系統
    • 電磁系統
    • 光學系統
  • 神經刺激設備
    • 深層腦部刺激器
    • 迷走神經刺激設備

第9章 神經外科器械市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 研究所
  • 專科診所

第10章 按應用分類的神經外科器械市場

  • 腦腫瘤
  • 癲癇
  • 水腦症
  • 運動障礙
  • 疼痛管理
  • 脊髓疾病

第11章 依手術方式分類的神經外科器械市場

  • 內視鏡手術
  • 雷射治療
  • 微創手術
  • 開顱手術

第12章 各地區神經外科器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 神經外科器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國神經外科器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Zimmer Biomet Holdings, Inc.
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Integra LifeSciences Holdings Corporation
    • Penumbra, Inc.
    • Globus Medical, Inc.
Product Code: MRR-E370886767D8

The Neurosurgery Devices Market is projected to grow by USD 35.64 billion at a CAGR of 13.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.15 billion
Estimated Year [2025] USD 14.91 billion
Forecast Year [2032] USD 35.64 billion
CAGR (%) 13.27%

Comprehensive orientation to neurosurgery devices highlighting technological convergence, clinical adoption pressures, regulatory evolution and implications for strategic decision-making

Neurosurgery device development is advancing at an accelerated pace as technological innovation converges with changing care delivery models and heightened clinical expectations. The field now spans a spectrum from biologically active graft materials and sophisticated implantable systems to high-definition endoscopes and navigation platforms that enable precision procedures. Concurrently, clinical practice is shifting toward less invasive approaches, and health systems are demanding robust evidence of safety, efficacy, and economic value before adoption. These dynamics are reshaping procurement preferences, clinical workflows, and competitive positioning for manufacturers and suppliers.

In parallel, regulatory frameworks and payer expectations are emphasizing real-world outcomes and post-market surveillance, which increases the importance of integrated data capture and longitudinal clinical studies. Investors are responding by favoring companies that demonstrate not only technical differentiation but also reproducible clinical benefits and credible commercialization pathways. As a result, product roadmaps are being designed with modularity and interoperability in mind, anticipating integration with navigation systems, neurostimulation platforms, and digital clinical decision support.

This introduction sets the stage for an analysis that interlinks clinical trends, device innovation, end-user behavior, and broader geopolitical and regulatory shifts. The following sections examine transformative changes in the landscape, tariff-driven operational impacts, segmentation-specific insights, regional dynamics, competitive behaviors, actionable recommendations, research methodology, and concluding implications for leaders shaping the future of neurosurgical care.

Analysis of converging technological innovations, clinical practice shifts, regulatory tightening, and commercial realignments reshaping neurosurgery device development and adoption

The neurosurgery device landscape is undergoing a set of transformative shifts that are simultaneously technological, clinical, regulatory, and commercial. On the technological front, advances in imaging, electromagnetic and optical navigation, and miniaturized endoscopy are enabling surgeons to operate with greater precision and reduced collateral tissue damage. These improvements are complemented by refinements in implant materials and biologic adjuncts designed to enhance bone healing and neural tissue compatibility, thereby improving long-term patient outcomes. Robotic assistance and AI-enabled image guidance are moving from experimental to pragmatic tools that reduce variability and shorten learning curves for complex procedures.

Clinically, the movement toward minimally invasive techniques and outpatient settings is changing procedural mixes and driving demand for instruments and devices that support shorter procedure times and rapid recovery. Neurostimulation technologies, particularly deep brain and vagus nerve stimulation, are expanding indications and seeing renewed interest as understanding of neuromodulation mechanisms deepens. Simultaneously, an increased emphasis on patient-reported outcomes and quality metrics is raising the bar for clinical evidence required to support adoption and reimbursement.

Regulatory and reimbursement landscapes are also shifting, with agencies requiring more comprehensive post-market data and payers looking for demonstrable value in terms of reduced complications, shorter hospital stays, and improved functional outcomes. On the commercial side, partnerships between established medtech firms, specialty device innovators, and clinical research networks are accelerating product translation while changing competitive dynamics. Taken together, these shifts create both opportunities and elevated execution risk for companies that must align product innovation with clinical utility and regulatory rigor.

Evaluation of how tariff-driven cost pressures and supply chain adjustments have reshaped sourcing strategies, product design choices, and commercialization timelines across neurosurgical device makers

The implementation of new tariff measures in the United States during 2025 has prompted a cumulative set of operational and strategic responses across the neurosurgery devices ecosystem. Manufacturers that rely on international supply chains have confronted increased landed costs for components and finished goods, which in turn pressures margin structures and pricing strategies. In response, many organizations initiated near-term tactical measures such as reprioritizing production runs, increasing inventory buffers for critical components, and accelerating dual-source qualification to reduce exposure to single-country supply dependencies. Over a slightly longer horizon, the tariff environment has encouraged a reevaluation of geographic manufacturing footprints, with increased consideration of reshoring or diversification into alternative low-cost manufacturing regions.

Beyond direct cost effects, tariffs have affected partner selection, contract negotiation, and capital allocation decisions. Procurement teams are renegotiating supplier agreements to incorporate tariff pass-through clauses and to obtain more favorable lead times and quality guarantees. Strategic teams are revisiting product designs to simplify bill-of-materials complexity, reduce reliance on tariff-sensitive components, and explore material substitutions that maintain clinical performance while mitigating cost risk. Clinical and regulatory teams are also involved, since design changes can trigger additional validation work and regulatory submissions, thereby affecting time-to-market.

Moreover, the tariff-induced dynamics have had downstream effects on clinical adoption timelines and health system purchasing behavior, as providers factor in potential supply volatility and total cost of ownership when evaluating new devices. Investors and corporate development groups are likewise recalibrating valuation models and partnership timelines to reflect the heightened operational uncertainty. Overall, the cumulative impact of the tariff changes has accelerated supply chain modernization efforts and heightened the importance of resilient, compliant, and clinically focused commercialization strategies.

Segmentation-driven clinical and commercial intelligence linking product subcategories, end-user settings, applications, and procedure types to prioritize innovation and market entry choices

Segmentation analysis reveals nuanced opportunities and execution imperatives across product classes, end users, clinical applications, and procedural approaches. Product type segmentation spans biologics, endoscopes, implantable devices, instruments, navigation systems, and neurostimulators. Within biologics, the focus on bone grafts and growth factors highlights a demand for materials that integrate with host tissue and reduce revision risk, prompting developers to prioritize bioactivity, sterilization compatibility, and supply chain traceability. Endoscopes, differentiated into flexible and rigid designs, show distinct adoption patterns: flexible endoscopes are gaining traction in tortuous anatomy and outpatient procedures, while rigid endoscopes continue to be preferred for certain intracranial and spinal exposures due to image stability. Implantable devices subdivide into cranial and spinal implants, with cranial implants further segmented into cranial plates and dural substitutes and spinal implants emphasizing fusion cages and pedicle screws; insights here underscore the premium on implant biocompatibility, modularity, and ease of fixation to reduce operative time and complication rates. Instruments, encompassing drills and perforators, retractor systems, and ultrasonic aspirators, are being evaluated by clinical teams for ergonomics, sterilization cycles, and compatibility with minimally invasive access. Navigation systems, split between electromagnetic and optical platforms, must deliver registration accuracy and interoperability with imaging suites. Neurostimulators, categorized into deep brain stimulators and vagus nerve stimulators, are advancing through refined lead technologies and closed-loop programming options that support expanded therapeutic indications.

End user segmentation includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. Ambulatory surgical centers are driving demand for compact, cost-effective devices that enable same-day discharge, whereas hospitals prioritize systems that integrate with existing imaging and monitoring infrastructure and support complex case mixes. Research institutes and specialty clinics serve as early adopters, providing clinical evidence and proof-of-concept data that can accelerate broader adoption.

Application segmentation covers brain tumors, epilepsy, hydrocephalus, movement disorders, pain management, and spinal cord disorders. Each application imposes distinct clinical performance requirements, ranging from precision resection margins for oncologic procedures to long-term stimulation durability for movement and pain indications. Procedure segmentation encompasses endoscopic surgery, laser therapy, minimally invasive surgery, and open surgery, and these procedural contexts determine device form factors, sterilization regimens, and instrument sets. Synthesizing these segmentation lenses highlights where clinical unmet needs intersect with technological capability and where targeted evidence generation and commercialization investments will deliver highest impact.

Comparative regional assessment of clinical infrastructure, regulatory nuance, procurement behavior, and strategic pathways to accelerate adoption across major global territories

Regional dynamics are shaping both opportunity and operational planning, with distinct priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, consolidated health systems and progressive ambulatory surgical center networks are creating demand for devices that demonstrate clear economic and clinical value across diverse care settings. Regulatory pathways in the region are increasingly aligned with post-market evidence expectations, requiring manufacturers to invest in registries and outcomes tracking. The Europe, Middle East & Africa region presents a heterogeneous landscape where reimbursement mechanisms, hospital procurement practices, and clinical infrastructure vary widely; manufacturers seeking traction must tailor market access strategies to national health technology assessment processes and engage local clinical champions to navigate adoption barriers. In the Asia-Pacific region, rapid hospital infrastructure expansion, growing neurosurgical caseloads, and government-led investment in healthcare capacity are driving demand for scalable device solutions and localized manufacturing partnerships. Across all regions, supply chain resilience, regulatory harmonization efforts, and digital integration capabilities are differentiators that influence both purchasing decisions and long-term partnerships.

Transnational considerations further complicate regional strategies. Cross-border clinical trials, regulatory equivalence initiatives, and multiregional reimbursement pilots can accelerate global launches but require careful orchestration of regulatory filings, clinical evidence packages, and training programs. Manufacturers that design regional rollouts to leverage center-of-excellence partnerships, digital training platforms, and adaptive pricing structures are better positioned to translate early clinical uptake into sustained adoption and favorable procurement terms.

Strategic company behaviors and partnership models revealing how integrated platforms, specialty innovators, and contract manufacturing choices influence commercialization and scaling

Company-level behaviors reveal a competitive landscape where established medtech firms, focused device specialists, and innovative startups each play distinct roles in shaping the trajectory of neurosurgical care. Leading firms are investing in platform strategies that bundle hardware, software, and data services to create integrated solutions that lower clinical variability and provide measurable outcomes. At the same time, focused specialists and emerging companies are advancing point innovations-novel biologics, refined implant designs, or next-generation stimulation leads-that address specific clinical gaps and can be attractive targets for partnership or acquisition.

Across the ecosystem, commercialization strategies emphasize evidence generation, clinician training, and service models that support device uptime and clinical outcomes. Strategic partnerships between device manufacturers, imaging and navigation vendors, and academic centers are accelerating product validation and clinician endorsement. Manufacturing partners and contract service providers are also central to scalability, particularly for companies that elect to regionalize production to mitigate tariff and logistics risks. Additionally, firms that prioritize transparent pricing, robust post-market surveillance, and clear interoperability standards are finding smoother pathways into health system procurement processes. In aggregate, company insights point to a bifurcated market where platform incumbents focus on integrated solutions and specialty innovators pursue clinical differentiation, both needing disciplined execution across regulatory, clinical, and commercial dimensions.

Actionable cross-functional guidance for product development, supply resilience, evidence generation, and commercialization to secure durable adoption and competitive advantage

Industry leaders should take a prioritized, cross-functional approach that aligns product innovation with evidence generation, supply resilience, and customer-centric commercialization. First, embed clinical evidence planning early in development cycles so that trials, registries, and real-world data capture address the endpoints that matter to surgeons, payers, and purchasers. This anticipatory approach shortens commercialization timelines and enhances reimbursement positioning. Next, redesign supply chain strategies to reduce single-source exposure and to evaluate regional manufacturing or dual-sourcing where tariff risk or logistics disruption could materially affect time-to-surgery. Investing in supplier qualification and materials engineering can yield durable cost and quality advantages.

Commercially, tailor value propositions to specific end-user segments: ambulatory surgical centers seek compact, cost-effective solutions; hospitals demand interoperability and service reliability; specialty clinics value clinical performance and training. Develop modular platforms and compatible instrument ecosystems to reduce procurement friction and to enable incremental upgrades rather than wholesale replacements. Operationally, expand clinician training programs through digital simulation and proctoring models to accelerate surgeon proficiency and to capture early outcome data. Regulatory and quality teams should prepare for iterative submissions by documenting post-market surveillance plans and by building electronic data capture processes that support compliance with regional requirements.

Finally, pursue alliances that complement internal capabilities, whether for advanced navigation, biologic manufacturing, or clinical research networks. Prioritize commercial pilots with high-impact centers that can produce reproducible outcomes and serve as reference accounts. By executing on these recommendations, leaders can improve the odds of durable adoption and create defensible competitive positioning in a dynamic neurosurgical device landscape.

Transparent mixed-methods research approach integrating practitioner interviews, clinical literature, regulatory review, and scenario analysis to underpin robust conclusions

The findings synthesized in this summary are grounded in a mixed-methods research approach that combined qualitative expert interviews, targeted primary research with clinicians and purchasing leaders, and rigorous secondary analysis of clinical literature and regulatory documentation. Primary inputs included structured interviews with neurosurgeons, operating room managers, hospital procurement specialists, device engineers, and health economics experts to capture both clinical priorities and procurement dynamics. These perspectives were triangulated with peer-reviewed clinical studies, device registries, and public regulatory filings to validate clinical performance claims, safety profiles, and post-market obligations.

Analytical methods included thematic synthesis to identify principal clinical and commercial trends, scenario analysis to evaluate the operational impacts of tariff changes and supply chain disruptions, and segmentation mapping to align device attributes with end-user needs and procedural contexts. Quality assurance protocols ensured that all claims were corroborated by more than one source and that conflicting inputs were reconciled through follow-up interviews or sensitivity checks. Ethical and compliance considerations governed the handling of primary data, and anonymized summaries of interview findings were used to protect confidentiality while preserving the richness of practitioner insight.

This methodological framework supports robust, actionable conclusions by integrating practitioner insight with documentary evidence and by explicitly addressing areas of uncertainty through scenario planning and sensitivity assessment.

Synthesis of strategic imperatives and risk considerations that will determine which organizations succeed in advancing clinical adoption and commercial scale in neurosurgical care

The neurosurgery devices ecosystem sits at an inflection point where technology, clinical demand, regulatory expectations, and geopolitical factors converge to reshape investment and execution priorities. Opportunities are abundant for organizations that can align differentiated device capabilities with rigorous evidence generation, resilient supply chains, and tailored commercialization strategies for specific clinical and regional contexts. Conversely, companies that fail to plan for tariff-induced cost volatility, regulatory rigor, and the increasing demand for demonstrable outcomes risk slower adoption and eroded commercial returns.

Leaders should focus on building interoperable platforms, investing in clinician training and real-world evidence programs, and structuring supply chains to minimize disruption risk. Strategic partnerships and targeted M&A can accelerate access to complementary technologies and clinical channels, while prudent product design choices can reduce total cost of ownership for providers. Ultimately, success in this market will favor organizations that take a systems-thinking approach, integrating engineering excellence with clinical validation and adaptive commercialization models that reflect the realities of care delivery across regions and provider types.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of robotic-assisted neurosurgical platforms for precision tumor resection
  • 5.2. Rising demand for minimally invasive endoscopic tools in spinal neurosurgery procedures
  • 5.3. Integration of AI powered imaging systems for real time intraoperative navigation
  • 5.4. Development of biocompatible neural implants for chronic deep brain stimulation therapy
  • 5.5. Advances in optogenetic neuromodulation devices for targeted neural circuit regulation
  • 5.6. Growth of portable intraoperative MRI systems to enhance operating room efficiency
  • 5.7. Expansion of wireless wearable sensors for continuous postoperative neurological monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Devices Market, by Product Type

  • 8.1. Biologics
    • 8.1.1. Bone Grafts
    • 8.1.2. Growth Factors
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Implantable Devices
    • 8.3.1. Cranial Implants
      • 8.3.1.1. Cranial Plates
      • 8.3.1.2. Dural Substitutes
    • 8.3.2. Spinal Implants
      • 8.3.2.1. Fusion Cages
      • 8.3.2.2. Pedicle Screws
  • 8.4. Instruments
    • 8.4.1. Drills And Perforators
    • 8.4.2. Retractor Systems
    • 8.4.3. Ultrasonic Aspirators
  • 8.5. Navigation Systems
    • 8.5.1. Electromagnetic Systems
    • 8.5.2. Optical Systems
  • 8.6. Neurostimulators
    • 8.6.1. Deep Brain Stimulators
    • 8.6.2. Vagus Nerve Stimulators

9. Neurosurgery Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals
  • 9.3. Research Institutes
  • 9.4. Specialty Clinics

10. Neurosurgery Devices Market, by Application

  • 10.1. Brain Tumors
  • 10.2. Epilepsy
  • 10.3. Hydrocephalus
  • 10.4. Movement Disorders
  • 10.5. Pain Management
  • 10.6. Spinal Cord Disorders

11. Neurosurgery Devices Market, by Procedure

  • 11.1. Endoscopic Surgery
  • 11.2. Laser Therapy
  • 11.3. Minimally Invasive Surgery
  • 11.4. Open Surgery

12. Neurosurgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. Johnson & Johnson
    • 15.3.4. B. Braun Melsungen AG
    • 15.3.5. Zimmer Biomet Holdings, Inc.
    • 15.3.6. Abbott Laboratories
    • 15.3.7. Boston Scientific Corporation
    • 15.3.8. Integra LifeSciences Holdings Corporation
    • 15.3.9. Penumbra, Inc.
    • 15.3.10. Globus Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NEUROSURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NEUROSURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROSURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA NEUROSURGERY DEVICES MARKE